16.4
Sedantes e hipnóticos: descripción general
Los sedantes son fármacos que alivian la ansiedad, mientras que los hipnóticos inducen el sueño. Ambas clases de medicamentos suprimen la actividad ne…
Los sedantes pertenecen a una clase de drogas que calman al individuo, mientras que los hipnóticos inducen y mantienen el sueño. Ambas categorías funcionan ralentizando la actividad cerebral.
Los fármacos sedantes-hipnóticos suprimen la actividad del SNC de forma dependiente de la dosis. Los medicamentos más antiguos, como los barbitúricos, siguen una curva lineal, lo que los hace potencialmente mortales. Los medicamentos más nuevos, como las benzodiazepinas, se desvían de la curva lineal, lo que los hace útiles para el alivio a corto plazo.
Los fármacos sedantes-hipnóticos se dirigen principalmente a los canales iónicos activados por el ligando GABAA y a los GPCR de melatonina.
El neurotransmisor GABA se une y abre el canal iónico GABAA, permitiendo la entrada de iones cloruro, disminuyendo el potencial de reposo y, a su vez, inhibiendo la activación neuronal.
Los barbitúricos, las benzodiazepinas y los agentes más nuevos como el zolpidem se unen en diferentes sitios alostéricos del canalGABA A, promoviendo la unión a GABA y la supresión neuronal.
Además, la melatonina activa los GPCR MT1 y MT2 en el hipotálamo anterior, disminuyendo la activación neuronal y favoreciendo el sueño. Los análogos de la melatonina, como el ramelteon, son útiles para el insomnio sin ningún riesgo de dependencia.
View the full transcript and gain access to JoVE Core videos
Q1: What is the difference between sedatives and hypnotics?
Sedatives calm individuals by reducing anxiety, while hypnotics induce and maintain sleep. Both work by slowing brain activity and suppressing central nervous system activity in a dose-dependent manner. The key distinction lies in their primary effect: sedatives provide calming relief, whereas hypnotics facilitate sleep onset and continuation.
Q2: How do sedative-hypnotic drugs affect the brain at the molecular level?
Sedative-hypnotic drugs primarily target GABAA ligand-gated ion channels and melatonin GPCRs. When GABA binds to GABAA channels, chloride ions flow in, decreasing neuronal resting potential and inhibiting firing. Barbiturates, benzodiazepines, and zolpidem bind at different allosteric sites on GABAA channels, promoting GABA binding and enhancing neuronal suppression.
Q3: Why are barbiturates considered more dangerous than benzodiazepines?
Barbiturates follow a linear dose-response curve, meaning CNS depression increases proportionally with dose, potentially causing fatal overdose. Benzodiazepines deviate from this linear curve, providing a safety margin where only extremely high doses cause severe CNS depression. This non-linear relationship makes sedatives and hypnotics drugs benzodiazepines safer for short-term anxiety and sleep relief.
Q4: What role do melatonin receptors play in sleep induction?
Melatonin activates MT1 and MT2 GPCRs in the anterior hypothalamus, decreasing neuronal firing and promoting sleep. Melatonin analogs like ramelteon mimic these effects and are helpful for treating insomnia without dependency risk. This receptor-based mechanism offers an alternative to GABA-targeting drugs for sleep management.
Q5: How do different sedative-hypnotic drug classes bind to GABAA channels?
Barbiturates, benzodiazepines, and non-benzodiazepine drugs such as zolpidem bind at different allosteric sites on the GABAA channel. By binding to these distinct sites, each drug class promotes GABA binding and enhances the inhibitory effect on neurons. This differential binding explains why sedatives and hypnotics drugs miscellaneous agents have unique pharmacological profiles and clinical applications.
Q6: What determines the safety profile of sedative-hypnotic medications?
The dose-response relationship determines safety. Older medications like barbiturates follow a linear curve with narrow safety margins, while newer drugs like benzodiazepines have non-linear dose-response relationships, providing wider safety margins. Careful dosage consideration and patient response monitoring are vital for ensuring safe and beneficial effects of sedative-hypnotic medications.
Q7: What are the main categories of sedative-hypnotic drugs available?
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs like zolpidem. Each category targets different molecular sites and has distinct pharmacological properties. Understanding these categories helps healthcare professionals select appropriate medications based on patient needs, duration of treatment, and safety considerations.